Study protocol for a randomised controlled trial of diacerein versus

diacerein  Diacerein is a medicine that is used to relieve pain, stiffness and swelling of joints associated with osteoarthritis  Mechanism of Action: Diacerein is an anthraquinone derivative and a prodrug that is metabolised to rhein, a selective inhibitor of interleukin-1 It

Diacerein is in a class of substances called anthraquinones A slow-acting drug, it is intended to block actions of interleukin 1 beta protein, diacerein) show sustained release of drug for 39 and 48 hours However, F3 diacerein F7 contained gold nanoparticles same as F6 but 10 mg diacerein

The IUPHARBPS Guide to Pharmacology diacerein ligand page  Diacerein generic is an anti-inflammatory agent, prescribed for osteoarthritis and chronic inflammatory arthritis